Medical Termination of Pregnancy in End-Stage Renal Disease

Safety Considerations

The European Society of Cardiology guidelines indicate that mifepristone can be used up to 7 weeks gestation as an alternative to surgical evacuation in patients with end-stage renal disease (ESRD) 1
Patients with ESRD should be considered high-risk and managed in an experienced center with appropriate emergency support services 1
The European Heart Journal recommends that mifepristone be administered in a hospital setting with close monitoring due to potential complications related to the underlying renal condition 1, 2

Baseline assessment of renal function and electrolytes should be performed before the procedure in patients with ESRD 3
Evaluation for potential bleeding risks should be considered, as patients with ESRD may have platelet dysfunction 1
Close monitoring of vital signs and bleeding during the procedure is necessary in patients with ESRD 1
Monitoring for signs of infection is crucial, as immunocompromised ESRD patients may be at higher risk 2

Increased risk of bleeding due to uremic platelet dysfunction is a potential complication in ESRD patients 1
Potential for fluid and electrolyte imbalances is a concern in patients with ESRD 3
Higher risk of infection due to immunocompromised state is a potential complication in ESRD patients 2

Dilatation and evacuation remains the safest procedure for high-risk patients, including those with ESRD, according to the European Heart Journal 1, 2
Surgical evacuation has a lower risk of prolonged bleeding compared to medical termination, which may be advantageous in ESRD patients, although this is noted in Praxis Medical Insights, the European Heart Journal also recommends careful consideration of medical termination options 1

Pregnant women with renal disease typically have hypertension, which requires careful management 4
Foetal survival is markedly reduced and birth weight decreases with increases in creatinine levels in pregnant women with renal disease 4
Volume overload may increase and reduce drug responsiveness, potentially requiring salt restriction, loop diuretics, or dialysis 4
For pregnant women with ESRD who continue pregnancy, intensified hemodialysis (>36 hours per week) has been associated with better pregnancy outcomes 5